Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion type Assertion NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_head.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion description "[To test targeted candidate gene variation for association with subclinical CVD defined by carotid artery intima-media thickness (CIMT) and coronary artery calcification (CAC), 610 women participating in the Kronos Early Estrogen Prevention Study (KEEPS), a clinical trial of MHT to prevent progression of CVD, were genotyped for 13,229 single nucleotide polymorphisms (SNPs) within 764 genes from anticoagulant, procoagulant, fibrinolytic, or innate immunity pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_provenance.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion evidence source_evidence_literature NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_provenance.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion SIO_000772 23188791 NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_provenance.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion wasDerivedFrom befree-20140225 NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_provenance.
- NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_assertion wasGeneratedBy ECO_0000203 NP162892.RAnx82cor1FFRwKMRPZ1oS4Hto49a15AmgG1wzxY59Ha4130_provenance.